MedTrace Logo

Cathodal tDCS in Chronic Migraine: Neurophysiological Study and Pilot Therapeutic Trial

NCT02122237 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2015-05-28

No results posted yet for this study

Summary

Cathodal tDCS decreases the excitability of the cerebral cortex and its daily application during intercritical phase, may have a therapeutic effect in chronic migraine.

Conditions

  • Chronic Migraine

Interventions

DEVICE

Cefaly tDCS

Cefaly tDCS (transcranial direct current stimulation) is able to modify cortical excitability, in particular cathodal tDCS decreases it. The side effects of tDCS are minor, especially sensations of itching and scalp paresthesias.

Sponsors & Collaborators

  • University of Liege

    lead OTHER

Principal Investigators

  • Delphine Magis, MD,PhD · University of Liege

  • Jean Schoenen, MD,PhD · University of Liege

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2014-04-30
Completion
2014-09-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02122237 on ClinicalTrials.gov